tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Lantheus: Strategic Growth and Market Leadership in Radiopharmaceuticals Justify Buy Rating
PremiumRatingsLantheus: Strategic Growth and Market Leadership in Radiopharmaceuticals Justify Buy Rating
24d ago
Lantheus price target lowered to $109 from $122 at B. Riley
Premium
The Fly
Lantheus price target lowered to $109 from $122 at B. Riley
26d ago
Lantheus price target lowered to $120 from $134 at JonesResearch
Premium
The Fly
Lantheus price target lowered to $120 from $134 at JonesResearch
2M ago
Strategic Growth and Focus: Lantheus’s Positive Long-Term Outlook Justifies Buy Rating
PremiumRatingsStrategic Growth and Focus: Lantheus’s Positive Long-Term Outlook Justifies Buy Rating
2M ago
Lantheus reports Q1 adjusted EPS $1.53, consensus $1.65
Premium
The Fly
Lantheus reports Q1 adjusted EPS $1.53, consensus $1.65
2M ago
Lantheus cuts FY25 adjusted EPS view to $6.60-$6.70 from $7.00 – $7.20
Premium
The Fly
Lantheus cuts FY25 adjusted EPS view to $6.60-$6.70 from $7.00 – $7.20
2M ago
Lantheus Completes Acquisition of Evergreen Theragnostics
PremiumCompany AnnouncementsLantheus Completes Acquisition of Evergreen Theragnostics
4M ago
Lantheus completes acquisition of Evergreen Theragnostics
Premium
The Fly
Lantheus completes acquisition of Evergreen Theragnostics
4M ago
Lantheus price target lowered to $122 from $127 at B. Riley
Premium
The Fly
Lantheus price target lowered to $122 from $127 at B. Riley
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100